News

United Therapeutics Corporation (NASDAQ:UTHR) is one of the top cheap pharmaceutical stocks to buy now. H.C. Wainwright analyst Andrew Fein reiterated a Buy rating on United Therapeutics Corporation ...
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look ...
United Therapeutics will commence a tender offer to acquire all outstanding shares of Miromatrix for a purchase price of $3.25 per share in cash at closing (an aggregate of approximately $91 ...
Liquidia lands major victory in patent dispute with United Therapeutics Unlock URL Order Reprints Gift this Article ...
Looking at United Therapeutics’s peers in the therapeutics segment, some have already reported their Q4 results, giving us a hint as to what we can expect. BioMarin Pharmaceutical delivered year ...
United Therapeutics ( NASDAQ: UTHR) has entered into two accelerated share repurchase deal to buy back an aggregate of $1 billion of its common stock. The company will repurchase these shares as part ...
United Therapeutics added that “ [b]oth parties have the opportunity to request rehearing by the Federal Circuit with respect to the adverse portions of the Federal Circuit’s affirmance.” ...
Rothblatt's team at United Therapeutics has transplanted genetically edited organs from pigs into humans. In September 2021, the first pig-kidney transplant functioned in a brain-dead human.
In addition, United Therapeutics and Miromatrix file annual, quarterly and current reports and other information with the SEC, which are available to the public from commercial document-retrieval ...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. and EDEN PRAIRIE, Minn., Oct. 30, 2023 (GLOBE NEWSWIRE) -- United Therapeutics Corporation (UTHR) and Miromatrix Medical Inc. (MIRO) announced ...
United Therapeutics and Miromatrix are providing this information as of October 30, 2023 and undertake no obligation to update or revise the information contained in this press release whether as ...
United Therapeutics will commence a tender offer to acquire all outstanding shares of Miromatrix for a purchase price of $3.25 per share in cash at closing (an aggregate of approximately $91 ...